You are here

  • Home
  • Archive
  • Volume 104, Issue 24
  • Response to: ‘Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep!’

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Response to: ‘Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep!’
  1. John Erwin III1,2,
  2. Bernard Iung3
  1. 1 Division of Cardiology/Department of Internal Medicine, Scott and White Medical Center Temple, Temple, Texas, USA
  2. 2 Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, Texas, USA
  3. 3 Bichat Hospital, Paris, France
  1. Correspondence to Dr John Erwin III, Division of Cardiology/Department of Internal Medicine, Scott and White Medical Center Temple, Temple, TX 76508, USA; John.ErwinIII{at}bswhealth.org

http://dx.doi.org/10.1136/heartjnl-2018-313851

Statistics from Altmetric.com

    The Authors’ reply

    Thank you for your kind feedback1. The authors do not disagree with the confusion around the term ‘non-valvular atrial fibrillation’. Our attempt in this editorial2 was to highlight the similarities and dissimilarities within …

    View Full Text

    Footnotes

    • Contributors Both authors contributed to drafting and final approval of the letter.

    • Competing interests None declared.

    • Patient consent Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.

    Linked Articles